Literature DB >> 24196416

The evidence for treating hypertension in older people with dementia: a systematic review.

L C Beishon1, J K Harrison2, R H Harwood3, T G Robinson2, J R F Gladman3, S P Conroy4.   

Abstract

Hypertension and dementia commonly co-exist in older people, yet guidance is lacking on how to manage these co-existing conditions. The aim of this systematic review was to assess the evidence for the treatment of hypertension in older people with dementia. Medline, EMBASE, Cochrane Library and the national research register archives were searched. Inclusion criteria were: randomised controlled trial of hypertension treatment, included participants aged 65+ years, participants had a diagnosis of dementia (global cognitive decline for at least 6 months affecting daily function), and the study assessed cognitive outcomes using validated tools. Dementia prevention studies and poor quality studies were excluded. The initial search revealed 1178 papers of potential interest, of which 24 were selected for review and six met the full inclusion criteria. Trials included people with mild-to-moderate but not severe dementia; exclusion criteria for the trials were extensive. Four trials were placebo-controlled RCTs; the remaining two compared different antihypertensives. All trials reported MMSE scores at baseline and follow-up; four reported blood pressure changes at follow-up; and only three reported cardiovascular morbidity or mortality at follow-up. Only one of four placebo-controlled studies showed evidence of blood pressure reduction, but no clear evidence for benefit (or harm) from antihypertensives on cognition, physical function or other cardiovascular outcomes. We found no evidence to confirm or refute the hypothesis that treatment of hypertension in people with dementia leads to overall health benefit.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24196416     DOI: 10.1038/jhh.2013.107

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  30 in total

Review 1.  Clinical practice. Preventing falls in elderly persons.

Authors:  Mary E Tinetti
Journal:  N Engl J Med       Date:  2003-01-02       Impact factor: 91.245

2.  Trajectories of disability in the last year of life.

Authors:  Thomas M Gill; Evelyne A Gahbauer; Ling Han; Heather G Allore
Journal:  N Engl J Med       Date:  2010-04-01       Impact factor: 91.245

3.  Orthostatic hypotension in older adults. The Cardiovascular Health Study. CHS Collaborative Research Group.

Authors:  G H Rutan; B Hermanson; D E Bild; S J Kittner; F LaBaw; G S Tell
Journal:  Hypertension       Date:  1992-06       Impact factor: 10.190

4.  Dementia and disability outcomes in large hypertension trials: lessons learned from the systolic hypertension in the elderly program (SHEP) trial.

Authors:  M Di Bari; M Pahor; L V Franse; R I Shorr; J Y Wan; L Ferrucci; G W Somes; W B Applegate
Journal:  Am J Epidemiol       Date:  2001-01-01       Impact factor: 4.897

5.  Effects of telmisartan on cognition and regional cerebral blood flow in hypertensive patients with Alzheimer's disease.

Authors:  Kazumasa Kume; Haruo Hanyu; Hirofumi Sakurai; Yusuke Takada; Takeshi Onuma; Toshihiko Iwamoto
Journal:  Geriatr Gerontol Int       Date:  2011-09-19       Impact factor: 2.730

Review 6.  Dementia and antihypertensive treatment.

Authors:  Willem H Birkenhäger; Françoise Forette; Jan A Staessen
Journal:  Curr Opin Nephrol Hypertens       Date:  2004-03       Impact factor: 2.894

7.  Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial.

Authors:  Ruth Peters; Nigel Beckett; Francoise Forette; Jaakko Tuomilehto; Robert Clarke; Craig Ritchie; Adam Waldman; Ivan Walton; Ruth Poulter; Shuping Ma; Marius Comsa; Lisa Burch; Astrid Fletcher; Christopher Bulpitt
Journal:  Lancet Neurol       Date:  2008-07-07       Impact factor: 44.182

8.  High blood pressure and resilience to physical and cognitive decline in the oldest old: the Leiden 85-plus Study.

Authors:  Behnam Sabayan; Anna M Oleksik; Andrea B Maier; Mark A van Buchem; Rosalinde K E Poortvliet; Wouter de Ruijter; Jacobijn Gussekloo; Anton J M de Craen; Rudi G J Westendorp
Journal:  J Am Geriatr Soc       Date:  2012-11-05       Impact factor: 5.562

9.  Effect of nimodipine on memory after cerebral infarction.

Authors:  K H Sze; T C Sim; E Wong; S Cheng; J Woo
Journal:  Acta Neurol Scand       Date:  1998-06       Impact factor: 3.209

10.  Survival times in people with dementia: analysis from population based cohort study with 14 year follow-up.

Authors:  Jing Xie; Carol Brayne; Fiona E Matthews
Journal:  BMJ       Date:  2008-01-10
View more
  9 in total

1.  Cardiovascular drug use among people with cognitive impairment living in nursing homes in northern Sweden.

Authors:  Sofia Svahn; Hugo Lövheim; Ulf Isaksson; Per-Olof Sandman; Maria Gustafsson
Journal:  Eur J Clin Pharmacol       Date:  2020-01-08       Impact factor: 2.953

Review 2.  New horizons: the management of hypertension in people with dementia.

Authors:  Jennifer Kirsty Harrison; Veronika Van Der Wardt; Simon Paul Conroy; David J Stott; Tom Dening; Adam Lee Gordon; Pip Logan; Tomas James Welsh; Jaspal Taggar; Rowan Harwood; John R F Gladman
Journal:  Age Ageing       Date:  2016-11       Impact factor: 10.668

Review 3.  Antihypertensive withdrawal for the prevention of cognitive decline.

Authors:  Susan Jongstra; Jennifer K Harrison; Terry J Quinn; Edo Richard
Journal:  Cochrane Database Syst Rev       Date:  2016-11-01

Review 4.  Withdrawal of antihypertensive medication: a systematic review.

Authors:  Veronika van der Wardt; Jennifer K Harrison; Tomas Welsh; Simon Conroy; John Gladman
Journal:  J Hypertens       Date:  2017-09       Impact factor: 4.844

5.  Blood Pressure and All-Cause Mortality by Level of Cognitive Function in the Elderly: Results From a Population-Based Study in Rural Greece.

Authors:  Marios K Georgakis; Athanasios D Protogerou; Eleni I Kalogirou; Evangelia Kontogeorgi; Ioanna Pagonari; Fani Sarigianni; Sokratis G Papageorgiou; Elisabeth Kapaki; Charalampos Papageorgiou; Dimitrios Tousoulis; Eleni Th Petridou
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-07-19       Impact factor: 3.738

6.  Interactive effects of vascular risk burden and advanced age on cerebral blood flow.

Authors:  Katherine J Bangen; Daniel A Nation; Lindsay R Clark; Alexandrea L Harmell; Christina E Wierenga; Sheena I Dev; Lisa Delano-Wood; Zvinka Z Zlatar; David P Salmon; Thomas T Liu; Mark W Bondi
Journal:  Front Aging Neurosci       Date:  2014-07-07       Impact factor: 5.750

7.  The association between SBP and mortality risk differs with level of cognitive function in very old individuals.

Authors:  Bodil Weidung; Håkan Littbrand; Peter Nordström; Bo Carlberg; Yngve Gustafson
Journal:  J Hypertens       Date:  2016-04       Impact factor: 4.844

8.  p38 MAPK Inhibition Improves Synaptic Plasticity and Memory in Angiotensin II-dependent Hypertensive Mice.

Authors:  Hai-Long Dai; Wei-Yuan Hu; Li-Hong Jiang; Le Li; Xue-Feng Gaung; Zhi-Cheng Xiao
Journal:  Sci Rep       Date:  2016-06-10       Impact factor: 4.379

9.  Differential restoration of functional hyperemia by antihypertensive drug classes in hypertension-related cerebral small vessel disease.

Authors:  Masayo Koide; Osama F Harraz; Fabrice Dabertrand; Thomas A Longden; Hannah R Ferris; George C Wellman; David C Hill-Eubanks; Adam S Greenstein; Mark T Nelson
Journal:  J Clin Invest       Date:  2021-09-15       Impact factor: 14.808

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.